- Home
- FTRE vs GLRE Comparison
FTRE vs GLRE Comparison
Compare FTRE & GLRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- GLRE
- Stock Information
- Founded
- FTRE 1996
- GLRE 2004
- Country
- FTRE United States
- GLRE Cayman Islands
- Employees
- FTRE N/A
- GLRE N/A
- Industry
- FTRE Medical Specialities
- GLRE Property-Casualty Insurers
- Sector
- FTRE Health Care
- GLRE Finance
- Exchange
- FTRE Nasdaq
- GLRE Nasdaq
- Market Cap
- FTRE 469.0M
- GLRE 466.5M
- IPO Year
- FTRE N/A
- GLRE 2007
- Fundamental
- Price
- FTRE $5.28
- GLRE $14.40
- Analyst Decision
- FTRE Hold
- GLRE
- Analyst Count
- FTRE 11
- GLRE 0
- Target Price
- FTRE $17.10
- GLRE N/A
- AVG Volume (30 Days)
- FTRE 3.7M
- GLRE 91.3K
- Earning Date
- FTRE 05-12-2025
- GLRE 08-05-2025
- Dividend Yield
- FTRE N/A
- GLRE N/A
- EPS Growth
- FTRE N/A
- GLRE N/A
- EPS
- FTRE N/A
- GLRE 1.32
- Revenue
- FTRE $2,685,600,000.00
- GLRE $717,617,000.00
- Revenue This Year
- FTRE N/A
- GLRE N/A
- Revenue Next Year
- FTRE $1.33
- GLRE N/A
- P/E Ratio
- FTRE N/A
- GLRE $10.70
- Revenue Growth
- FTRE N/A
- GLRE 2.79
- 52 Week Low
- FTRE $3.97
- GLRE $11.95
- 52 Week High
- FTRE $28.41
- GLRE $15.82
- Technical
- Relative Strength Index (RSI)
- FTRE 53.54
- GLRE 64.38
- Support Level
- FTRE $3.97
- GLRE $14.00
- Resistance Level
- FTRE $4.46
- GLRE $14.56
- Average True Range (ATR)
- FTRE 0.37
- GLRE 0.32
- MACD
- FTRE 0.20
- GLRE 0.05
- Stochastic Oscillator
- FTRE 78.92
- GLRE 81.06
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About GLRE Greenlight Capital Re Ltd.
Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.